TribLIVE

| Neighborhoods


Most serious charges dropped in Ringgold pill case

About The Tribune-Review
The Tribune-Review can be reached via e-mail or at 412-321-6460.
Contact Us | Video | RSS | Mobile


By Trib Total Media

Published: Friday, February 1, 2013, 1:16 a.m.
Updated: Friday, February 1, 2013

Three felony drug counts were withdrawn Thursday against a Ringgold High School senior accused of distributing prescription narcotics during lunch period.

However, Christopher Pagano, 18, of Finleyville, was ordered to stand trial on three misdemeanor counts of possession of a controlled substance after he waived his right to a preliminary hearing before Magisterial District Judge Mark Wilson in Monongahela.

On Jan. 14, Wilson sent Pagano to the Washington County Correctional Facility in lieu of $10,000 bond. Pagano was released after he posted bond the next day.

Carroll Township police were called to the school Dec. 5 after Pagano allegedly made hand-to-hand transactions of prescription narcotics during lunch period, according to an affidavit of probable cause.

Police allege Pagano traded Vicoden to another juvenile for Xanax during a Nov. 30 lunch period. That juvenile then distributed the pills to three other students, two of whom admitted to ingesting the pills.

Most Popular Mon Valley

  1. Charleroi boy hit by car listed in good condition
  2. Alleged scrap metal thieves face trial in Monongahela
  3. School bomb threats precede stick-up at Bentleyville bank
  4. Donora physician, wife were victims of disaster
  5. Eight seek seats on Washington County bench
  6. Reward offered in Monessen pharmacy robbery
  7. Marcellus shale testing to start in Perry Township
  8. ’43 Memorial Day rites led by dedication of honor roll
  9. Corrected election results from BVA, Ringgold races
  10. Parking meters seen as double-edged swords
  11. Lucas, Costanzo lead ballot in Washington County
You must be signed in to add comments

To comment, click the Sign in or sign up at the very top of this page.

There are currently no comments for this story.
Subscribe today! Click here for our subscription offers.